In addition to the advanced therapies we currently provide, newly installed radiation oncology technology at MUSC Hollings Cancer Center offers patients a nonsurgical, specialized form of treatment that can be completed in five or fewer outpatient sessions, each lasting 20 minutes or less.
is an advanced cancer treatment system that treats patients with stereotactic radiosurgery, a noninvasive method of treating tumors with high-dose radiation precisely matched to the size and shape of the tumor. This pinpoint accuracy minimizes radiation exposure to healthy tissue and allows physicians to customize treatment for different types of cancer, including more complex cases.
Dr. Joseph Jenrette III, chairman of the Department of Radiation Oncology at MUSC, and his team provide clinical direction for the TrueBeam STx program.
According to Dr. Jenrette, TrueBeam STx provides important benefits for patients.
“TrueBeam STx will allow us to enhance the patient experience by significantly reducing treatment time to five or fewer visits, which will allow patients who receive the treatment to spend more time with their families and to focus on other activities. TrueBeam STx can give hope to patients with inoperable or surgically complex tumors, as well as those seeking an alternative to surgery or conventional radiation therapy.”
TrueBeam STx is capable of treating cancerous and noncancerous tumors in the body, including the lung, brain, prostate, spine, liver, pancreas, kidney, bone and eye. It can also treat certain blood vessel abnormalities, as well as trigeminal neuralgia, a neuropathic disorder that causes intense facial pain.
Treatments with TrueBeam STx will be available at the MUSC Health main campus in downtown Charleston. Our first patient will be treated with TrueBeam STx on August 13.
Patients are currently being accepted for TrueBeam STx consultations. Call 843-792-3271 to request more information and find out if you or a loved one may be a candidate for TrueBeam STx treatment.